Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets
- 5 July 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (2) , 253-262
- https://doi.org/10.1016/0006-2952(91)90711-d
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prostaglandin E1 and arterial occlusive disease: pharmacological considerationsEuropean Journal of Clinical Investigation, 1988
- Hemodynamic and angiographic effects of prostaglandin E1 in coronary artery diseaseThe American Journal of Cardiology, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Intracellular mechanism of action of vasodilatorsEuropean Heart Journal, 1988
- Randomized trial of prostacyclin infusion in acute myocardial infarctionThe American Journal of Cardiology, 1988
- Platelets and Antiplatelet Therapy in Ischemic Heart DiseaseMedical Clinics of North America, 1988
- Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.Circulation Research, 1987
- Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1986
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976